In safe hands: regulatory affairs at MSD
The translation of MSD authorisation documents is entrusted to professionals who have in-depth knowledge of the subject and are familiar with the requirements of Swissmedic, the EMA and the FDA. To ensure linguistic consistency, they work with Trados CAT tools and use translation memories hosted by Apostroph. The final step is comparative proofreading, which checks the completeness and accuracy of the translation in accordance with the ISO 17100 quality standard. Before delivery is made to MSD, however, our project management team completes the pharmaceutical company’s “Translation Review Checklist”, thus ensuring the customer’s internal quality process.
A science in itself: the translation of scientific content
Our catalogue of tasks at MSD includes approval certificates, letters with medical content, specialist information and scientific studies, where individual texts have to be notarised. It goes without saying that assignments of this kind place high demands on our language professionals in terms of content and terminology. However, as they are trained in the pharmaceutical or medical sectors and thus possess the requisite expertise, MSD is always in good hands with Apostroph.
Find out more about specialist pharmaceutical translations
Apostroph with international links to MSD
The pharmaceutical company uses a global platform solution to organise language management uniformly in all countries. Apostroph joined this project a few years ago. Now, offer requests, order placement and reporting options take place directly on this platform. Translation assets can also be exchanged directly and in an optimised manner via the system.
Find out more about language management consulting
Some of the services Apostroph provides for MSD:
Would you like to receive regular updates on new customer projects and news about Apostroph?
In our newsletter, we will surprise you with articles that are as informative as they are entertaining. We would be delighted to welcome you to our community of 20,000 newsletter followers.